Data on timing of any serious adverse events Study Description An open label study to describe the safety and pharmacokinetics of intravenous acyclovir in premature infants with suspected systemic her
Dataset (Stata v15.1) containing responses from a survey of UK Clinical Research Collaboration registered clinical trial units (CTUs) and industry statisticians from both pharmaceuticals and clinical
*p-value from a comparison of the three treatment groups using Fisher's exact test. % refers to the proportion of children who reported an adverse event on any occasion after drug administration.
